X-linked creatine transporter defect is caused by mutations in SLC6A8 at Xq28, which encodes the sodium-dependent creatine transporter. Reduction in creatine uptake results in elevated urine creatine and CSF creatine deficiency, which can be detected on magnetic resonance spectroscopy. We report a patient who was initially suspected of having a mitochondrial disorder but was later found to have a creatine transporter defect. The abnormal laboratory study results seen in this patient suggesting a mitochondrial cytopathy could be due to excess mitochondrial stress as well as the mitochondrial inclusion bodies. This report looks at the mitochondrial presentation of the creatine transporter deficiency.
Salomons GS, Van Dooren SJM, Verhoeven M., et al. X-linked creatine transporter defect: an overview. J Inherit Metab Dis. 2003;26:309-318.
2.
Anslem IM, Alkuraya FS, Salmons GS, et al. X-linked creatine transporter defect: a report on two unrelated boys with a severe clinical phenotype. J Inherit Metab Dis . 2006;29:214-219.
Tarnopolsky MA, Roy BD, MacDonald JRA randomized, controlled trial of creatine monohydrate in patients with mitochondrial cytopathies. Muscle Nerve. 1997;20:1502-1509.
5.
Rosenberg EH , Almeida LS, Kleefstra T., et al. High prevalence of SLC6A8 deficiency of X-linked mental retardation. Am J Hum Genet. 2004;75:97-105.
6.
Brustovetsky N., Brustovetsky T., Dubinsky JMOn the mechanisms of neuroprotection by creatine and phosphocreatine. J Neurochem . 2001;76:425-434.
7.
O’Gorman E., Fuchs KH, Tittmann P., Gross H., Wallimann T.Crystalline mitochondrial inclusion bodies isolated from creatine depleted rat soleus muscle. J Cell Sci. 1997;110(12):1403-1411.
